About this trial
Retrospective case-control study to assess the diagnostic accuracy in autism spectrum disorder (ASD) of a new smartphone-based platform designed to conduct neurometric evaluations by measuring facial and behavioural reflexes.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Male or female individuals between the ages of 3 - 12 years old at the time of consent.
Caregiver must be able to read, understand and sign the Informed Consent Form (ICF).
Normal or corrected-to-normal vision with visual acuity sufficient to watch short videos.
Hearing adequate to hear the auditory stimuli delivered via headphones.
Disqualifiers
Participants under 3 or over 12 years old.
Severe hearing or visual impairment.
Participants using medication that affects the nervous system (classified as ATC N0 medication, https://www.whocc.no).
Trial design
Single group
Treatments tested in this trial
Blinklab diagnostic device
Diagnostic testBlinklab is a non-invasive diagnostic device for Autism Spectrum Disorder
Treatment groups
Trial outcomes
Primary outcomes
Device Sensitivity
Measure of the proportion of children truly having ASD who are correctly identified by the device as Positive for ASD relative to a formal DSM-5 diagnosis
Device Specificity
Measure of the proportion of children truly not having ASD (who had no prior psychiatric diagnosis) who are correctly identified by the device as Negative for ASD
Secondary outcomes
Screen Avoidance
The percentage of trials wherein the child was avoiding the smartphone's screen and camera
Anteroposterior Postural Stability
The child's anteroposterior postural stability
Head Rotations
The percentage of trials wherein the child was rotating their head
Headphone Touches
The percentage of trials wherein the child was touching the headphone
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Blinklab Limited
Lead sponsor
Mohammed VI National Center for the Disabled, Salé, Morocco
Collaborator